Oxurion (TBGNF) News Today $0.17 0.00 (0.00%) As of 09/19/2023 Add Compare Share Share Headlines Stock AnalysisBuy This Stock TBGNF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Oxurion confirms progress in negotiations related to its treasury diversification strategy; closing of the transaction expected before September 25, 2025September 1 at 2:36 PM | actusnews.comOXURION: Oxurion confirms progress in negotiations related to its treasury diversification strategy; closing of the transaction expected before September 25, 2025September 1 at 2:36 PM | finanznachrichten.deOXURION: Oxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of AxiodisJuly 11, 2025 | finanznachrichten.deOxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of AxiodisJuly 11, 2025 | actusnews.comOxurion moves forward with the planned acquisition of AxiodisJune 13, 2025 | actusnews.comOXURION: Oxurion moves forward with the planned acquisition of AxiodisJune 12, 2025 | finanznachrichten.deOxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CROMay 17, 2025 | actusnews.comOXURION: Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CROMay 17, 2025 | finanznachrichten.deOXURION: Publication Annual Report - Annual Shareholders' MeetingApril 11, 2025 | finanznachrichten.deOXURION: Postponement Annual Shareholders MeetingApril 4, 2025 | finanznachrichten.deOXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLCApril 2, 2025 | finanznachrichten.deOxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLCMarch 27, 2025 | actusnews.comOxurion Receives Transparency Notifications from Atlas Special Opportunities II LLCMarch 27, 2025 | actusnews.comOxurion NV Reports Significant Shareholding ChangesMarch 27, 2025 | tipranks.comOxurion NV to Acquire French CRO Specializing in BiometricsMarch 18, 2025 | tipranks.comOxurion signs a letter of intent for the planned acquisition of a biometrics-focused CROMarch 18, 2025 | actusnews.comOXURION: Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CROMarch 18, 2025 | finanznachrichten.deOxurion Extends Its Financing ProgramMarch 4, 2025 | actusnews.comOxurion NV Extends Convertible Bond Financing ProgramMarch 4, 2025 | tipranks.comOxurion strengthens its Board of Directors with the arrival of Nelly SouleymaneFebruary 14, 2025 | actusnews.comOxurion NV Strengthens Board with New AppointmentFebruary 14, 2025 | tipranks.comOXURION: Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLCJanuary 14, 2025 | finanznachrichten.deOxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLCJanuary 14, 2025 | actusnews.comOxurion Updates on Atlas Shareholding ChangesJanuary 14, 2025 | tipranks.comOxurion Expands Capital to Enhance Ophthalmic InnovationsJanuary 13, 2025 | tipranks.comOxurion Receives Significant Shareholding Notification from AtlasJanuary 6, 2025 | tipranks.comOxurion NV Expands Capital for Innovative Eye CareJanuary 3, 2025 | tipranks.comOxurion NV Delays Strategic Transaction SigningDecember 31, 2024 | tipranks.comFrench Authorities Approve Oxurion's Strategic Transaction Under Specific ConditionsDecember 20, 2024 | actusnews.comOxurion NV Gains Approval for Strategic TransactionDecember 19, 2024 | tipranks.comOxurion’s Shareholder Atlas Reduces StakeDecember 12, 2024 | tipranks.comOxurion Sees Stake Reduction by Atlas Special OpportunitiesDecember 4, 2024 | tipranks.comOxurion announces that its potential acquisition is subject to foreign investment controlNovember 29, 2024 | actusnews.comOxurion Awaits French Approval for AcquisitionNovember 28, 2024 | tipranks.comOXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLCOctober 3, 2024 | finanznachrichten.deOXURION: Oxurion Publishes First Half 2024 ResultsSeptember 30, 2024 | finanznachrichten.deOxurion Publishes First Half 2024 ResultsSeptember 30, 2024 | actusnews.comOXURION: Oxurion: Progress in the Fight Against Age-Related Macular DegenerationSeptember 14, 2024 | finanznachrichten.deOXURION: Oxurion: Progress in the Fight Against AMDSeptember 12, 2024 | finanznachrichten.deOxurion: Progress in the Fight Against AMDSeptember 12, 2024 | actusnews.comOXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLCSeptember 4, 2024 | finanznachrichten.deOxurion Share ConsolidationJuly 25, 2024 | uk.finance.yahoo.comOxurion NV: Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMDMay 6, 2024 | finanznachrichten.deOxurion NV: Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program: Eleventh tranche fully issued and paid-upApril 10, 2024 | finanznachrichten.deOxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully issued and paid-upApril 10, 2024 | markets.businessinsider.comOxurion NV: Postponement Annual Shareholders Meeting - Amendment financial calendarApril 5, 2024 | finanznachrichten.deOxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended versionMarch 27, 2024 | finanznachrichten.deOxurion Receives EUR 300,000 in the framework of the Atlas Funding Program Tenth tranche fully issued and paid-upMarch 5, 2024 | finance.yahoo.comOxurion NV: Oxurion Announces New Strategic Orientation to De-risk and DiversifyJanuary 22, 2024 | finanznachrichten.deOxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor AtlasDecember 28, 2023 | finance.yahoo.com Get Oxurion News Delivered to You Automatically Sign up to receive the latest news and ratings for TBGNF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TBGNF Media Mentions By Week TBGNF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TBGNF News Sentiment▼0.001.11▲Average Medical News Sentiment TBGNF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TBGNF Articles This Week▼20▲TBGNF Articles Average Week Get the Latest News and Ratings for TBGNF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oxurion and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals News Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Ascentage Pharma Group International News Ascletis Pharma News Avacta Group News Awakn Life Sciences News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:TBGNF) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxurion NV Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxurion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TBGNF Stock Alerts